What are the major opportunities in the Neonatal Respiratory Distress Syndrome Treatment market? What are the strategies for the Neonatal Respiratory Distress Syndrome Treatment market?

For detailed insights on the major opportunities and strategies in the Neonatal Respiratory Distress Syndrome Treatment market, Read More

How does the Neonatal Respiratory Distress Syndrome Treatment market relate to the overall economy and other similar markets?

For detailed insights on Neonatal Respiratory Distress Syndrome Treatment's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Neonatal Respiratory Distress Syndrome Treatment market growth? SWOT analysis of the Neonatal Respiratory Distress Syndrome Treatment market.

For detailed insights on the key dynamics influencing the Neonatal Respiratory Distress Syndrome Treatment market growth and SWOT analysis of the Neonatal Respiratory Distress Syndrome Treatment industry, Read More

Global Neonatal Respiratory Distress Syndrome Treatment Market Report 2025

Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Neonatal Respiratory Distress Syndrome Treatment Global Market Report 2025

Name: Neonatal Respiratory Distress Syndrome Treatment Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Therapy (Oxygen Therapy, Surfactant Therapy), By Route Of Administration (Parenteral, Inhalation, Other Routes Of Administration), By End User (Hospitals, Sub-Acute Facilities, Home Care, Retail Pharmacies) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Neonatal Respiratory Distress Syndrome Treatment Market Overview

• Neonatal Respiratory Distress Syndrome Treatment market size has reached to $0.96 billion in 2024

• Expected to grow to $1.39 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%

• Growth Driver: Rising Premature Birth Rates Fuel Growth In The Market

• Market Trend: Advancements In Non-Invasive Respiratory Treatments For Neonates With Hypoxic Respiratory Failure

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Neonatal Respiratory Distress Syndrome Treatment Market?

Neonatal respiratory distress syndrome treatment refers to the management of premature infants with insufficient surfactant production, leading to breathing difficulties. It involves administering exogenous surfactant therapy, providing respiratory support with mechanical ventilation or continuous positive airway pressure (CPAP), and oxygen supplementation.

The main types of therapy for neonatal respiratory distress syndrome treatment include oxygen therapy and surfactant therapy. Oxygen therapy involves the administration of oxygen to patients who are unable to obtain sufficient oxygen through normal breathing. It can be administered through parenteral, inhalation, and others and is used by hospitals, sub-acute facilities, home care, and retail pharmacies.

Neonatal Respiratory Distress Syndrome Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Neonatal Respiratory Distress Syndrome Treatment Market Size 2025 And Growth Rate?

What Is The Neonatal Respiratory Distress Syndrome Treatment Market Growth Forecast?

The neonatal respiratory distress syndrome treatment market size is expected to see strong growth in the next few years. It will grow to $1.39 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing preference for accessories and consumables, rising NICU admissions, increasing demand for personalized medicine, increasing premature birth, increasing research and development activities. Major trends in the forecast period include automation in neonatal intensive care units (NICUs), integration of artificial intelligence (AI), technological advancement in neonatal care, surfactant therapy innovation, advanced ventilator technologies.

The forecast of 7.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. Neonatal intensive care units by driving up the cost of surfactant replacements and high-frequency ventilators sourced from Ireland and France, exacerbating respiratory crisis management and increasing critical care expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Neonatal Respiratory Distress Syndrome Treatment Market Segmented?

1) By Therapy: Oxygen Therapy, Surfactant Therapy

2) By Route Of Administration: Parenteral, Inhalation, Other Routes Of Administration

3) By End User: Hospitals, Sub-Acute Facilities, Home Care, Retail Pharmacies

Subsegments:

1) By Oxygen Therapy: Conventional Oxygen Therapy, High-Flow Nasal Cannula (HFNC) Oxygen Therapy, Continuous Positive Airway Pressure (CPAP) Oxygen Therapy, Invasive Mechanical Ventilation With Oxygen Therapy

2) By Surfactant Therapy: natural surfactants, Synthetic Surfactants, Combined Surfactant Therapy (Natural + Synthetic), Prophylactic Surfactant Therapy, Rescue Surfactant Therapy

What Is Driving The Neonatal Respiratory Distress Syndrome Treatment Market? Rising Premature Birth Rates Fuel Growth In The Market

The rise in incidence of premature births is expected to propel the growth of the neonatal respiratory distress syndrome treatment market going forward. Premature birth, or preterm birth, happens when a baby is born before 37 weeks of pregnancy, with those born before 32 weeks facing the most severe health risks, as a typical pregnancy lasts about 40 weeks. Premature births are increasing due to factors such as older maternal age, multiple pregnancies, health conditions, lifestyle choices, use of fertility treatments, infections, and environmental factors. Neonatal respiratory distress syndrome (NRDS) is commonly required for premature infants due to their underdeveloped lungs and insufficient production of surfactant. This treatment helps improve lung function, stabilize breathing, and reduce the risk of respiratory failure in premature babies. For instance, in December 2022, according to Tommy’s, a UK-based charity organization, the percentage of premature live births in England and Wales reached 7.9% in 2022, up from 7.5% in 2021. This marks the second consecutive year of an increase in premature births. Over 53,000 babies were born prematurely in 2022. Therefore, the rise in incidence of premature births is driving the neonatal respiratory distress syndrome treatment industry.

Who Are The Major Players In The Global Neonatal Respiratory Distress Syndrome Treatment Market?

Major companies operating in the neonatal respiratory distress syndrome treatment market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Medtronic Plc, Medline Industries, Becton Dickinson, Stryker Corporation, GE Healthcare, Koninklijke Philips NV, ResMed Inc., Drägerwerk AG & Co. KGaA, Chiesi Farmaceutici, ICU Medical Inc., Fisher & Paykel Healthcare, Vyaire Medical, Laerdal Medical, Hamilton Medical, Inspiration Healthcare, Ventec Life Systems, Neotech Products, Aerogen Pharma Corp., Windtree Therapeutics Inc., Discovery Laboratories Inc., Lyomark Pharma GmbH

What Are The Key Trends Of The Global Neonatal Respiratory Distress Syndrome Treatment Market? Advancements In Non-Invasive Respiratory Treatments For Neonates With Hypoxic Respiratory Failure

Major companies operating in the neonatal respiratory distress syndrome treatment market are concentrating on developing advanced technologies, such as nitric oxide generators, to enhance oxygenation, minimize respiratory complications, and offer non-invasive treatments for neonates with hypoxic respiratory failure. A nitric oxide generator is a medical device that generates and administers nitric oxide gas, commonly used to treat respiratory issues by improving oxygenation and alleviating pulmonary hypertension, particularly in neonates and critically ill patients. For instance, in June 2022, Beyond Air Inc., a US-based medical device and biopharmaceutical company, received FDA approval for LungFit PH. This innovative nitric oxide generator is designed to treat term and near-term neonates with hypoxic respiratory failure, including persistent pulmonary hypertension of the newborn (PPHN). Using Beyond Air's patented Ionizer technology, the device generates nitric oxide on demand from ambient air, providing an unlimited supply without concerns about dose or flow, and utilizes a low-power compressor to ionize nitrogen and oxygen, minimizing nitrogen dioxide (NO2) production, which is then safely filtered out via a smart filter.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Neonatal Respiratory Distress Syndrome Treatment Market? Chiesi Group Partners With Oak Hill Bio To Develop OHB-607 For Neonatal BPD Treatment

In January 2024, Chiesi Group, an Italy-based biopharmaceutical company, partnered with Oak Hill Bio to develop neonatal therapies. This collaboration focuses on the development and commercialization of OHB-607, a groundbreaking treatment aimed at preventing severe bronchopulmonary dysplasia (BPD) and its long-term respiratory effects in preterm infants, particularly those born before 28 weeks gestational age with low IGF-1 levels. Oak Hill Bio is a UK-based company developing therapies for neonatal and rare diseases.

What Is The Regional Outlook For The Global Neonatal Respiratory Distress Syndrome Treatment Market?

North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Neonatal Respiratory Distress Syndrome Treatment Market?

The neonatal respiratory distress syndrome treatment market consists of revenues earned by entities by providing services such as surfactant administration services, neonatal respiratory care consulting, telemedicine, and remote monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The neonatal respiratory distress syndrome treatment market also includes sales of mechanical ventilators, continuous positive airway pressure (CPAP) machines, high-frequency ventilators, and neonatal incubators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Neonatal Respiratory Distress Syndrome Treatment Industry?

The neonatal respiratory distress syndrome treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neonatal respiratory distress syndrome treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Neonatal Respiratory Distress Syndrome Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.03 billion
Revenue Forecast In 2034	$1.39 billion
Growth Rate	CAGR of 7.9% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The neonatal respiratory distress syndrome treatment market covered in this report is segmented – 1) By Therapy: Oxygen Therapy, Surfactant Therapy 2) By Route Of Administration: Parenteral, Inhalation, Other Routes Of Administration 3) By End User: Hospitals, Sub-Acute Facilities, Home Care, Retail Pharmacies Subsegments: 1) By Oxygen Therapy: Conventional Oxygen Therapy, High-Flow Nasal Cannula (HFNC) Oxygen Therapy, Continuous Positive Airway Pressure (CPAP) Oxygen Therapy, Invasive Mechanical Ventilation With Oxygen Therapy 2) By Surfactant Therapy: Natural Surfactants, Synthetic Surfactants, Combined Surfactant Therapy (Natural + Synthetic), Prophylactic Surfactant Therapy, Rescue Surfactant Therapy
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Merck & Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Medtronic Plc, Medline Industries, Becton Dickinson, Stryker Corporation, GE Healthcare, Koninklijke Philips NV, ResMed Inc., Drägerwerk AG & Co. KGaA, Chiesi Farmaceutici, ICU Medical Inc., Fisher & Paykel Healthcare, Vyaire Medical, Laerdal Medical, Hamilton Medical, Inspiration Healthcare, Ventec Life Systems, Neotech Products, Aerogen Pharma Corp., Windtree Therapeutics Inc., Discovery Laboratories Inc., Lyomark Pharma GmbH
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Neonatal Respiratory Distress Syndrome Treatment Market Characteristics

3. Neonatal Respiratory Distress Syndrome Treatment Market Trends And Strategies

4. Neonatal Respiratory Distress Syndrome Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Neonatal Respiratory Distress Syndrome Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Neonatal Respiratory Distress Syndrome Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Neonatal Respiratory Distress Syndrome Treatment Market Growth Rate Analysis

5.4. Global Neonatal Respiratory Distress Syndrome Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Neonatal Respiratory Distress Syndrome Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Neonatal Respiratory Distress Syndrome Treatment Total Addressable Market (TAM)

6. Neonatal Respiratory Distress Syndrome Treatment Market Segmentation

6.1. Global Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oxygen Therapy

Surfactant Therapy

6.2. Global Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Parenteral

Inhalation

Other Routes Of Administration

6.3. Global Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Sub-Acute Facilities

Home Care

Retail Pharmacies

6.4. Global Neonatal Respiratory Distress Syndrome Treatment Market, Sub-Segmentation Of Oxygen Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Conventional Oxygen Therapy

High-Flow Nasal Cannula (HFNC) Oxygen Therapy

Continuous Positive Airway Pressure (CPAP) Oxygen Therapy

Invasive Mechanical Ventilation With Oxygen Therapy

6.5. Global Neonatal Respiratory Distress Syndrome Treatment Market, Sub-Segmentation Of Surfactant Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Natural Surfactants

Synthetic Surfactants

Combined Surfactant Therapy (Natural + Synthetic)

Prophylactic Surfactant Therapy

Rescue Surfactant Therapy

7. Neonatal Respiratory Distress Syndrome Treatment Market Regional And Country Analysis

7.1. Global Neonatal Respiratory Distress Syndrome Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Neonatal Respiratory Distress Syndrome Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market

8.1. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neonatal Respiratory Distress Syndrome Treatment Market

9.1. China Neonatal Respiratory Distress Syndrome Treatment Market Overview

9.2. China Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neonatal Respiratory Distress Syndrome Treatment Market

10.1. India Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neonatal Respiratory Distress Syndrome Treatment Market

11.1. Japan Neonatal Respiratory Distress Syndrome Treatment Market Overview

11.2. Japan Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neonatal Respiratory Distress Syndrome Treatment Market

12.1. Australia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neonatal Respiratory Distress Syndrome Treatment Market

13.1. Indonesia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neonatal Respiratory Distress Syndrome Treatment Market

14.1. South Korea Neonatal Respiratory Distress Syndrome Treatment Market Overview

14.2. South Korea Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market

15.1. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market Overview

15.2. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neonatal Respiratory Distress Syndrome Treatment Market

16.1. UK Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neonatal Respiratory Distress Syndrome Treatment Market

17.1. Germany Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neonatal Respiratory Distress Syndrome Treatment Market

18.1. France Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neonatal Respiratory Distress Syndrome Treatment Market

19.1. Italy Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neonatal Respiratory Distress Syndrome Treatment Market

20.1. Spain Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market

21.1. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market Overview

21.2. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neonatal Respiratory Distress Syndrome Treatment Market

22.1. Russia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neonatal Respiratory Distress Syndrome Treatment Market

23.1. North America Neonatal Respiratory Distress Syndrome Treatment Market Overview

23.2. North America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neonatal Respiratory Distress Syndrome Treatment Market

24.1. USA Neonatal Respiratory Distress Syndrome Treatment Market Overview

24.2. USA Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neonatal Respiratory Distress Syndrome Treatment Market

25.1. Canada Neonatal Respiratory Distress Syndrome Treatment Market Overview

25.2. Canada Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neonatal Respiratory Distress Syndrome Treatment Market

26.1. South America Neonatal Respiratory Distress Syndrome Treatment Market Overview

26.2. South America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neonatal Respiratory Distress Syndrome Treatment Market

27.1. Brazil Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neonatal Respiratory Distress Syndrome Treatment Market

28.1. Middle East Neonatal Respiratory Distress Syndrome Treatment Market Overview

28.2. Middle East Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neonatal Respiratory Distress Syndrome Treatment Market

29.1. Africa Neonatal Respiratory Distress Syndrome Treatment Market Overview

29.2. Africa Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neonatal Respiratory Distress Syndrome Treatment Market Competitive Landscape And Company Profiles

30.1. Neonatal Respiratory Distress Syndrome Treatment Market Competitive Landscape

30.2. Neonatal Respiratory Distress Syndrome Treatment Market Company Profiles

30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis

31. Neonatal Respiratory Distress Syndrome Treatment Market Other Major And Innovative Companies

31.1. Medline Industries

31.2. Becton Dickinson

31.3. Stryker Corporation

31.4. GE Healthcare

31.5. Koninklijke Philips NV

31.6. ResMed Inc.

31.7. Drägerwerk AG & Co. KGaA

31.8. Chiesi Farmaceutici

31.9. ICU Medical Inc.

31.10. Fisher & Paykel Healthcare

31.11. Vyaire Medical

31.12. Laerdal Medical

31.13. Hamilton Medical

31.14. Inspiration Healthcare

31.15. Ventec Life Systems

32. Global Neonatal Respiratory Distress Syndrome Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neonatal Respiratory Distress Syndrome Treatment Market

34. Recent Developments In The Neonatal Respiratory Distress Syndrome Treatment Market

35. Neonatal Respiratory Distress Syndrome Treatment Market High Potential Countries, Segments and Strategies

35.1 Neonatal Respiratory Distress Syndrome Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Neonatal Respiratory Distress Syndrome Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Neonatal Respiratory Distress Syndrome Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Neonatal Respiratory Distress Syndrome Treatment Market, Sub-Segmentation Of Oxygen Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Neonatal Respiratory Distress Syndrome Treatment Market, Sub-Segmentation Of Surfactant Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Neonatal Respiratory Distress Syndrome Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Neonatal Respiratory Distress Syndrome Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Indonesia, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: South Korea, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Western Europe, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: UK, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Germany, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: France, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Italy, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Spain, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Eastern Europe, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Russia, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: North America, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: USA, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Canada, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: South America, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Brazil, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Middle East, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Africa, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Merck & Co. Inc. Financial Performance

Table 77: AbbVie Inc. Financial Performance

Table 78: Bayer AG Financial Performance

Table 79: Abbott Laboratories Financial Performance

Table 80: Medtronic Plc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Neonatal Respiratory Distress Syndrome Treatment Market, Sub-Segmentation Of Oxygen Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Neonatal Respiratory Distress Syndrome Treatment Market, Sub-Segmentation Of Surfactant Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Neonatal Respiratory Distress Syndrome Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Neonatal Respiratory Distress Syndrome Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Indonesia, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: South Korea, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Western Europe, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: UK, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Germany, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: France, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Italy, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Spain, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Eastern Europe, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Russia, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: North America, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: USA, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Canada, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: South America, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Brazil, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Middle East, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Africa, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Merck & Co. Inc. Financial Performance

Figure 77: AbbVie Inc. Financial Performance

Figure 78: Bayer AG Financial Performance

Figure 79: Abbott Laboratories Financial Performance

Figure 80: Medtronic Plc Financial Performance

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Pediatric And Neonatal Testing Kit Global Market Report 2025 – By Test Type (Dried Blood Spot, Hearing Screening, Critical Congenital Heart Defect (CCHD), Other Test Types), By Product (Assay Kits And Reagents, Instrumen...

Respiratory Disease Testing Global Market Report 2025 – By Test Type (Imaging Tests, Mechanical Tests, In-Vitro Diagnostic Tests), By Products (Lung Volume, Imaging, Spirometry, Peak Flow, Blood Gas, Other Products), By ...

Neonatal Intensive Care Units (NICU) Catheters Global Market Report 2025 – By Type (Peripherally Inserted Central Catheters (PICCs), Central Venous Catheters (CVCs), Umbilical Venous Catheters (UVCs), Other Types), By Ap...

Severe Acute Respiratory-Syndrome Treatment Global Market Report 2025 – By Drug Class (Antibiotics, Antiviral, Corticosteroids, Monoclonal Antibodies, Other Drug Classes), By Route Of Administration (Oral, Intravenous), ...

Neonatal Infant Care Global Market Report 2025 – By Product Type( Thermoregulation Devices, Phototherapy Devices, Monitoring Systems, Neonatal Hearing Screening, Neonatal Infant Resuscitator Devices, Vision Screening, Ot...

Acute Respiratory Distress Syndrome (ARDS) Global Market Report 2025 – By Type (Diagnosis, Treatment), By Cause (COVID-19 Disease 2019 (COVID-19), Sepsis, Inhalation Of Harmful Substances, Severe Pneumonia, Other Causes)...

Lower Respiratory Tract Therapeutics Global Market Report 2025 – By Disease Type (Asthma, Chronic obstructive pulmonary disease, Pneumonia, Tuberculosis, Bronchitis, Other Diseases), By Drug Class (Antibiotics, Non-Stero...

Frequently Asked Questions

What is the definition of the Neonatal Respiratory Distress Syndrome Treatment market?

How will the Neonatal Respiratory Distress Syndrome Treatment market drivers and restraints affect the market dynamics? What forces will shape the Neonatal Respiratory Distress Syndrome Treatment industry going forward?

The market major growth driver - Rising Premature Birth Rates Fuel Growth In The Market. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Neonatal Respiratory Distress Syndrome Treatment market?

The neonatal respiratory distress syndrome treatment market size has grown strongly in recent years. It will grow from $0.96 billion in 2024 to $1.03 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increasing permeability and fluid accumulation within the alveoli, increasing alveolar-capillary permeability, increase in utilization of mechanical ventilation, increasing awareness among healthcare providers and parents about the importance of neonatal care, increasing healthcare investments. The neonatal respiratory distress syndrome treatment market size is expected to see strong growth in the next few years. It will grow to " $1.39 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing preference for accessories and consumables, rising NICU admissions, increasing demand for personalized medicine, increasing premature birth, increasing research and development activities. Major trends in the forecast period include automation in neonatal intensive care units (NICUs), integration of artificial intelligence (AI), technological advancement in neonatal care, surfactant therapy innovation, advanced ventilator technologies. For further insights on this market, request a sample here

How is the Neonatal Respiratory Distress Syndrome Treatment market segmented?

The neonatal respiratory distress syndrome treatmentmarket covered in this report is segmented –
1) By Therapy: Oxygen Therapy; Surfactant Therapy
2) By Route Of Administration: Parenteral; Inhalation; Other Routes Of Administration
3) By End User: Hospitals; Sub-Acute Facilities; Home Care; Retail Pharmacies Subsegments:
1) By Oxygen Therapy: Conventional Oxygen Therapy; High-Flow Nasal Cannula (HFNC) Oxygen Therapy; Continuous Positive Airway Pressure (CPAP) Oxygen Therapy; Invasive Mechanical Ventilation With Oxygen Therapy
2) By Surfactant Therapy: Natural Surfactants; Synthetic Surfactants; Combined Surfactant Therapy (Natural + Synthetic); Prophylactic Surfactant Therapy; Rescue Surfactant Therapy For further insights on this market, request a sample here

Which region has the largest share of the Neonatal Respiratory Distress Syndrome Treatment market? What are the other regions covered in the report?

North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal respiratory distress syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Neonatal Respiratory Distress Syndrome Treatment market?

What are the key trends in the Neonatal Respiratory Distress Syndrome Treatment market?

Major trends in this market include Advancements In Non-Invasive Respiratory Treatments For Neonates With Hypoxic Respiratory Failure. For further insights on this market, request a sample here.